These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31672785)

  • 1. Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in Breast Cancer.
    Ge Y; Böhm HH; Rathinasamy A; Xydia M; Hu X; Pincha M; Umansky L; Breyer C; Hillier M; Bonertz A; Sevko A; Domschke C; Schuetz F; Frebel H; Dettling S; Herold-Mende C; Reissfelder C; Weitz J; Umansky V; Beckhove P
    Cancer Immunol Res; 2019 Dec; 7(12):1998-2012. PubMed ID: 31672785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1.
    Rathinasamy A; Domschke C; Ge Y; Böhm HH; Dettling S; Jansen D; Lasitschka F; Umansky L; Gräler MH; Hartmann J; Herold-Mende C; Schuetz F; Beckhove P
    Cancer Immunol Immunother; 2017 May; 66(5):593-603. PubMed ID: 28224210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dormant tumor cells interact with memory CD8
    Flores-Guzmán F; Utikal J; Umansky V
    Cancer Lett; 2020 Apr; 474():74-81. PubMed ID: 31962142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
    Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
    J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.
    Bai L; Beckhove P; Feuerer M; Umansky V; Choi C; Solomayer FS; Diel IJ; Schirrmacher V
    Int J Cancer; 2003 Jan; 103(1):73-83. PubMed ID: 12455056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice.
    Knutson KL; Dang Y; Lu H; Lukas J; Almand B; Gad E; Azeke E; Disis ML
    J Immunol; 2006 Jul; 177(1):84-91. PubMed ID: 16785502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity.
    Kochin V; Nishikawa H
    Nagoya J Med Sci; 2019 Feb; 81(1):1-18. PubMed ID: 30962651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors.
    Umansky V; Abschuetz O; Osen W; Ramacher M; Zhao F; Kato M; Schadendorf D
    Cancer Res; 2008 Nov; 68(22):9451-8. PubMed ID: 19010920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses.
    Oh DS; Kim H; Oh JE; Jung HE; Lee YS; Park JH; Lee HK
    Oncotarget; 2017 Jul; 8(29):47440-47453. PubMed ID: 28537894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma.
    Bonertz A; Weitz J; Pietsch DH; Rahbari NN; Schlude C; Ge Y; Juenger S; Vlodavsky I; Khazaie K; Jaeger D; Reissfelder C; Antolovic D; Aigner M; Koch M; Beckhove P
    J Clin Invest; 2009 Nov; 119(11):3311-21. PubMed ID: 19809157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity.
    Perret R; Sierro SR; Botelho NK; Corgnac S; Donda A; Romero P
    Cancer Res; 2013 Nov; 73(22):6597-608. PubMed ID: 24048821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
    Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
    Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells.
    Umansky V; Sevko A
    Pigment Cell Melanoma Res; 2013 Jul; 26(4):457-63. PubMed ID: 23560814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow contains melanoma-reactive CD8+ effector T cells and, compared with peripheral blood, enriched numbers of melanoma-reactive CD8+ memory T cells.
    Letsch A; Keilholz U; Assfalg G; Mailänder V; Thiel E; Scheibenbogen C
    Cancer Res; 2003 Sep; 63(17):5582-6. PubMed ID: 14500398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches.
    Horn T; Grab J; Schusdziarra J; Schmid S; Maurer T; Nawroth R; Wolf P; Pritsch M; Gschwend JE; Kübler HR; Beckhove P
    Int J Cancer; 2013 Nov; 133(9):2145-56. PubMed ID: 23625723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma.
    Tähtinen S; Blattner C; Vähä-Koskela M; Saha D; Siurala M; Parviainen S; Utikal J; Kanerva A; Umansky V; Hemminki A
    J Immunother; 2016; 39(9):343-354. PubMed ID: 27741089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity.
    Pedros C; Canonigo-Balancio AJ; Kong KF; Altman A
    JCI Insight; 2017 Dec; 2(23):. PubMed ID: 29212947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients.
    Feuerer M; Rocha M; Bai L; Umansky V; Solomayer EF; Bastert G; Diel IJ; Schirrmacher V
    Int J Cancer; 2001 Apr; 92(1):96-105. PubMed ID: 11279612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients.
    Bailur JK; Gueckel B; Derhovanessian E; Pawelec G
    Breast Cancer Res; 2015 Mar; 17(1):34. PubMed ID: 25849846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.